Stay updated on SL-401 Combo With Pomalid/Dex in MM Clinical Trial
Sign up to get notified when there's something new on the SL-401 Combo With Pomalid/Dex in MM Clinical Trial page.
Latest updates to the SL-401 Combo With Pomalid/Dex in MM Clinical Trial page
- Check3 days agoChange DetectedNew research articles have been added focusing on the roles of interleukin-3 in various hematological malignancies and the impact of cancer stem cells on treatment resistance, while several older articles have been removed.SummaryDifference44%
- Check10 days agoChange DetectedThe website has added new features for user interaction while removing detailed options for participant groups, interventions, and various data fields related to studies.SummaryDifference3%
- Check17 days agoChange DetectedThe website has been updated to version v2.12.2, introducing new features for downloading data in various formats and allowing users to select specific fields for export.SummaryDifference3%
- Check31 days agoChange DetectedThe website has been updated from version 2.12.0 to 2.12.1.SummaryDifference0.1%
- Check39 days agoChange DetectedSeveral new studies have been added, focusing on the role of interleukin-3 in various hematological malignancies and the impact of cancer stem cells on treatment outcomes, while previous entries have been removed, including detailed citations of similar research.SummaryDifference40%
- Check61 days agoChange DetectedThe website has been updated from version 2.11.0 to 2.11.2, indicating new features or improvements.SummaryDifference0.0%
Stay in the know with updates to SL-401 Combo With Pomalid/Dex in MM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SL-401 Combo With Pomalid/Dex in MM Clinical Trial page.